Industry Spotlight

Pfizer adds AstraZeneca's antibiotics business

25 August 2016 via Biotech Dispatch: Pfizer has quickly followed its US$14 billion takeover of Medivation by agreeing to acquire AstraZenecas small molecule antibiotics business in a deal that could be worth in excess of US$1.5 billion. The agreement includes the co... | READ MORE

New senior appointments for IQ Group Global

25 August 2016 via Biotech Dispatch: The iQ Group Global has announced two recent promotions within their executive team - officially appointing Jimena Hurtado as General Manager of their Clinical Research Corporation (CRC) business and Lei Xu as Director of their As... | READ MORE

Medlab completes cannabis supply agreement ahead of trial

23 August 2016 via Biotech Dispatch: Medical life science company, Medlab (ASX:MDC), has signed a cannabis supply agreement with Canadian licensed producer of medical marijuana, Aphria. Cannabis plant species, yields and a novel extraction process have been establis... | READ MORE

First 3D map of cell-building protein linked to cancer

23 August 2016 via Biotech Dispatch: Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular map of a protein that has been pinpointed as a driver of many types of cancers. The view of the protein doublecortin kin... | READ MORE

Adelaide biotech company Reproductive Health Science to launch latest product to global market

18 August 2016 via BiotechDispatch: Adelaide-based biotechnology company Reproductive Health Science (ASX:RHS) is launching its second product, DOPlify onto the global market. DOPlify was introduced at the recent European Society of Human Reproduction and Embryology... | READ MORE

CSL expecting strong growth ahead

18 August 2016 via Biotech Dispatch: CSL says it expects growth to continue for the year ahead after announcing 8.2 per cent growth in revenue for the past year. According to CEO Paul Perreault, the companys net profit after tax is expected to grow at around 11 per ... | READ MORE

Cochlear breaks $1bn in sales

11 August 2016 via Biotech Dispatch: Australian hearing implant company Cochlear has posted annual revenues of over $1 billion, up 23 per cent on the year before, and a 30 per cent rise in net profit to $189 million. According to CEO and President, Chris Smith, &ldq... | READ MORE

Mesoblast announces positive phase II RA results

11 August 2016 via Biotech Dispatch: Mesoblast (ASX:MSB) has announced that a single intravenous infusion of its allogeneic Mesenchymal Precursor Cell (MPC) product candidate, MPC-300-IV, was well tolerated and demonstrated a dose-related improvement in clinical symp... | READ MORE

Johnson and Johnson backs health innovation competition

9 August 2016 via Biotech Dispatch: Johnson & Johnson ;is backing an opportunity for local start-ups to compete in a competition aimed at developing innovative, tech-based solutions for the pressing health issues facing Australians. The Heath and Technology Challeng... | READ MORE

$18 million to boost global collaboration

9 August 2016 via Biotech Dispatch: The Turnbull Government has announced grants of up to $1 million to help researchers collaborate with global partners on leading-edge research, development and commercialisation projects. The Governments Global Innovation Linkages... | READ MORE

Previous page | Next page
Jump to page